FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
暂无分享,去创建一个
J. Yamauchi | R. Bottino | H. Harashima | R. Muzumdar | A. García-Ocaña | H. H. Dong | Dae Hyun Kim | Ting Zhang | Zhenwei Gong | Rennian Wang | G. Gittes | Xiangwei Xiao | Sojin Lee | V. Calabuig-Navarro | J. Álvarez-Pérez | D. Kim
[1] P. Reynolds,et al. Insulin demand regulates β cell number via the unfolded protein response. , 2015, The Journal of clinical investigation.
[2] D. Accili,et al. Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function , 2015, Diabetes.
[3] M. Prentki,et al. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. , 2014, Cell metabolism.
[4] D. Accili,et al. FOXO1 Inhibition Yields Functional Insulin-Producing Cells In Human Gut Organoid Cultures , 2014, Nature Communications.
[5] T. Kitamura. The role of FOXO1 in β-cell failure and type 2 diabetes mellitus , 2013, Nature Reviews Endocrinology.
[6] Maike Sander,et al. Inactivation of specific β cell transcription factors in type 2 diabetes. , 2013, The Journal of clinical investigation.
[7] L. Alonso,et al. Adaptive β-cell proliferation increases early in high-fat feeding in mice, concurrent with metabolic changes, with induction of islet cyclin D2 expression. , 2013, American journal of physiology. Endocrinology and metabolism.
[8] Carly R. Kibbe,et al. FOXO1 Competes with Carbohydrate Response Element-binding Protein (ChREBP) and Inhibits Thioredoxin-interacting Protein (TXNIP) Transcription in Pancreatic Beta Cells* , 2013, The Journal of Biological Chemistry.
[9] Amy E. Cox,et al. Human Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas , 2013, Diabetes.
[10] Katarzyna A. Broniowska,et al. Differential responses of pancreatic β-cells to ROS and RNS. , 2013, American journal of physiology. Endocrinology and metabolism.
[11] C. Talchai,et al. Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure , 2012, Cell.
[12] S. Ellard,et al. SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion , 2012, Diabetologia.
[13] Sylvia Lee. Faculty Opinions recommendation of Generation of functional insulin-producing cells in the gut by Foxo1 ablation. , 2012 .
[14] T. Kitamura,et al. FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization , 2012, PloS one.
[15] T. Kitamura,et al. Overexpression of FoxO1 in the hypothalamus and pancreas causes obesity and glucose intolerance. , 2012, Endocrinology.
[16] Zhongming Ma,et al. FTY720 Normalizes Hyperglycemia by Stimulating β-Cell in Vivo Regeneration in db/db Mice through Regulation of Cyclin D3 and p57KIP2* , 2011, The Journal of Biological Chemistry.
[17] S. Ringquist,et al. FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver , 2011, Diabetes.
[18] D. Accili,et al. FoxO Feedback Control of Basal IRS-2 Expression in Pancreatic β-Cells Is Distinct From That in Hepatocytes , 2011, Diabetes.
[19] F. Ashcroft,et al. Control of pancreatic β cell regeneration by glucose metabolism. , 2011, Cell metabolism.
[20] A. F. Stewart,et al. Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD–severe combined immunodeficiency (SCID) mice , 2011, Diabetologia.
[21] J. Corbett,et al. FoxO1 and SIRT1 Regulate β-Cell Responses to Nitric Oxide* , 2011, The Journal of Biological Chemistry.
[22] S. Ringquist,et al. FoxO1 links hepatic insulin action to endoplasmic reticulum stress. , 2010, Endocrinology.
[23] J. Crapo,et al. Redox Modulation Protects Islets From Transplant-Related Injury , 2010, Diabetes.
[24] H. H. Dong,et al. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas , 2010, Diabetologia.
[25] Jiang Hu,et al. Cyclin D2 Is Essential for the Compensatory β-Cell Hyperplastic Response to Insulin Resistance in Rodents , 2010, Diabetes.
[26] Huan Sun,et al. Overexpression of FoxO1 causes proliferation of cultured pancreatic beta cells exposed to low nutrition. , 2010, Biochemistry.
[27] R. DePinho,et al. Regulation of Pancreatic Juxtaductal Endocrine Cell Formation by FoxO1 , 2009, Molecular and Cellular Biology.
[28] D. Stoffers,et al. Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. , 2009, Molecular endocrinology.
[29] I. Shiojima,et al. mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability* , 2009, Journal of Biological Chemistry.
[30] D. Harlan,et al. Blood Glucose Levels Regulate Pancreatic β-Cell Proliferation during Experimentally-Induced and Spontaneous Autoimmune Diabetes in Mice , 2009, PloS one.
[31] M. Laakso,et al. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.
[32] M. Meseck,et al. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. , 2008, The Journal of clinical investigation.
[33] R. Rizza,et al. β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.
[34] M. Permutt,et al. Inhibition of Foxo1 Protects Pancreatic Islet β-Cells Against Fatty Acid and Endoplasmic Reticulum Stress–Induced Apoptosis , 2008, Diabetes.
[35] B. Topp,et al. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. , 2007, American journal of physiology. Endocrinology and metabolism.
[36] R. Kaufman,et al. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? , 2007, Antioxidants & redox signaling.
[37] N. Zhang,et al. Angiopoietin-1 Production in Islets Improves Islet Engraftment and Protects Islets From Cytokine-Induced Apoptosis , 2007, Diabetes.
[38] Seung K. Kim,et al. Glucose Infusion in Mice , 2007, Diabetes.
[39] J. Altomonte,et al. PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1 , 2007 .
[40] D. Accili,et al. Metabolic Diapause in Pancreatic β-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1* , 2007, Journal of Biological Chemistry.
[41] H. Aburatani,et al. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. , 2007, The Journal of clinical investigation.
[42] J. Altomonte,et al. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. , 2006, Endocrinology.
[43] Min-Seon Kim,et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis , 2006, Nature Neuroscience.
[44] M. Prentki,et al. Islet beta cell failure in type 2 diabetes. , 2006, The Journal of clinical investigation.
[45] Hua V. Lin,et al. Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. , 2006, The Journal of clinical investigation.
[46] H. Kaneto,et al. The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation* , 2006, Journal of Biological Chemistry.
[47] Robert Tjian,et al. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. , 2005, Genes & development.
[48] D. Accili,et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.
[49] Hendrik C Korswagen,et al. Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling , 2005, Science.
[50] P. B. Jensen,et al. The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] U. Boggi,et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. , 2005, Diabetes.
[52] R. Robertson. Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.
[53] B. Topp,et al. Metabolic adaptations to chronic glucose infusion in rats , 2004, Diabetologia.
[54] D. Accili,et al. FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.
[55] M. Lane,et al. Convergence of Peroxisome Proliferator-activated Receptor γ and Foxo1 Signaling Pathways* , 2003, Journal of Biological Chemistry.
[56] Robert A. Rizza,et al. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.
[57] Y. Kido,et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. , 2002, The Journal of clinical investigation.
[58] D. Accili,et al. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.
[59] S. Aizawa,et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.
[60] G. Shulman,et al. Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.
[61] J. Leahy,et al. The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. , 1992, The Journal of clinical investigation.
[62] J. Leahy,et al. Compensatory Growth of Pancreatic β-Cells in Adult Rats After Short-Term Glucose Infusion , 1989, Diabetes.
[63] A. Tannapfel,et al. Cell cycle control of β-cell replication in the prenatal and postnatal human pancreas. , 2011, American journal of physiology. Endocrinology and metabolism.
[64] R. Robertson,et al. Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .